Skip to content
AdminApr 22, 2020< 1 min read

Aetion, HealthVerity collaborate on real-world data for COVID-19 treatments

Aetion and HealthVerity are playing to their strengths with the joint launch of new tools to support biopharmas and regulators gauging new COVID-19 treatments. The first, called the Real-Time Evidence Platform, is built on an instance of Aetion's platform and focuses on up-to-date usage, safety, and effectiveness data. The Real-Time Trend Reporting and Interactive Data Visualizer, meanwhile, looks to demonstrate COVID-19's overall impact and how patients are currently accessing health care.

Read More

Admin

RELATED ARTICLES

AdminApr 22, 2020< 1 min read

Aetion, HealthVerity Launch New Tools for Assessing COVID-19 Treatments

Aetion® and HealthVerity have launched a new set of tools for biopharma companies and regulators looking to assess new ...
Start Reading
AdminJan 9, 20255 min read

Aetion Appoints CEO and New Executive Chair of the Board

Dr. Jeremy Rassen, co-founder of Aetion and current board director, will resume his leadership role as Aetion’s CEO
Start Reading
AdminMay 19, 2020< 1 min read

FDA, Aetion partner on real-world data analytics for COVID-19

The US Food and Drug Administration (FDA) on Tuesday said it will partner with New York-based health technology firm Aetion to ...
Start Reading